{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T16:50:29Z","timestamp":1760547029939},"reference-count":12,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[1999,4,1]],"date-time":"1999-04-01T00:00:00Z","timestamp":922924800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,24]],"date-time":"2019-12-24T00:00:00Z","timestamp":1577145600000},"content-version":"vor","delay-in-days":7572,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[1999,4]]},"DOI":"10.1023\/a:1008397424359","type":"journal-article","created":{"date-parts":[[2002,12,22]],"date-time":"2002-12-22T09:41:38Z","timestamp":1040550098000},"page":"475-478","source":"Crossref","is-referenced-by-count":17,"title":["Paclitaxel and gemcitabine in advanced non-nasopharyngeal head and neck cancer: A phase II study conducted by the Hellenic Cooperative Oncology Group"],"prefix":"10.1016","volume":"10","author":[{"given":"G.","family":"Fountzilas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Stathopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Nicolaides","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Kalogera-Fountzila","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Kalofonos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Nikolaou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Bacoyiannis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Samantas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Papadimitriou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Kosmidis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Daniilidis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Pavlidis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1023\/A:1008397424359_bb0005","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/oxfordjournals.annonc.a010467","article-title":"Chemotherapy for squamous cell carcinoma of head and neck. The future is now","volume":"7","author":"Vokes","year":"1996","journal-title":"Ann Oncol"},{"key":"10.1023\/A:1008397424359_bb0010","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1200\/JCO.1992.10.2.257","article-title":"A phase III randomized study comparing cisplatin and fluorouracil as single agents and in combination for advanced squamous cell carcinoma or the head and neck","volume":"10","author":"Jacobs","year":"1992","journal-title":"J Clin Oncol"},{"key":"10.1023\/A:1008397424359_bb0015","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1002\/(SICI)1097-0142(19980601)82:11<2270::AID-CNCR24>3.0.CO;2-Q","article-title":"Final report of a phase II evaluation of paclitaxel in patients with advanced squamous cell carcinoma of the head and neck: An Eastern Cooperative Oncology Group Trial (PA 390)","volume":"82","author":"Forastiere","year":"1998","journal-title":"Cancer"},{"key":"10.1023\/A:1008397424359_bb0020","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1093\/oxfordjournals.annonc.a058908","article-title":"Docetaxel (Taxotere): An active drug of the treatment of patients with advanced squamous cell carcinoma of the head and neck","volume":"5","author":"Catimel","year":"1994","journal-title":"Ann Oncol"},{"key":"10.1023\/A:1008397424359_bb0025","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1093\/oxfordjournals.annonc.a058910","article-title":"A phase II study of gemcitabine (LY 188011) in patients with advanced squamous cell carcinoma of the head and neck","volume":"5","author":"Catimel","year":"1994","journal-title":"Ann Oncol"},{"key":"10.1023\/A:1008397424359_bb0030","first-page":"825","article-title":"Interaction of gemcitabine with paclitaxel and cisplatin in human tumor cell lines","volume":"12","author":"Theodossiou","year":"1998","journal-title":"Int J Oncol"},{"key":"10.1023\/A:1008397424359_bb0035","first-page":"869","article-title":"In vitro cross resistance and collateral sensitivity in seven resistant small-cell lung cancer cell lines","volume":"75","author":"Jensen","year":"1997","journal-title":"Preclinical identification of suitable drug partners to Taxotere, topotecan and gemcitabine Br J Cancer"},{"issue":"Suppl 1","key":"10.1023\/A:1008397424359_bb0040","first-page":"45","article-title":"Paclitaxel and carboplatin as first-line chemotherapy for advanced breast cancer","volume":"12","author":"Fountzilas","year":"1998","journal-title":"Oncology"},{"issue":"Suppl 8","key":"10.1023\/A:1008397424359_bb0045","doi-asserted-by":"crossref","first-page":"S121","DOI":"10.1016\/S0959-8049(97)85063-0","article-title":"Phase I study to investigate alternate sequencing of the combination of gemcitabine and paclitaxel in ovarian carcinoma","volume":"33","author":"Poole","year":"1997","journal-title":"Eur J Cancer"},{"key":"10.1023\/A:1008397424359_bb0050","first-page":"451","article-title":"PacHtaxel by three-hour infusion and carboplatin in advanced carcinoma of nasopharynx and other sites of the head and neck","volume":"8","author":"Fountzilas","year":"1997","journal-title":"A phase II study Ann Oncol"},{"key":"10.1023\/A:1008397424359_bb0055","first-page":"44","article-title":"Gemcitabine and paclitaxel combinations m non-small-cell lung cancer","volume":"25","author":"Dombernowsky","year":"1998","journal-title":"Semin Oncol"},{"key":"10.1023\/A:1008397424359_bb0060","first-page":"1127","volume":"9","author":"Androulakis","year":"1998","journal-title":"Salvage treatment with paclitaxel and gemcitabine for patients with non- small-cell lung cancer after cisplatin-or docetaxel-based chemotherapy A multicenter phase II study."}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419571654?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419571654?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/10\/4\/475\/19477455\/10-4-475.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,20]],"date-time":"2020-02-20T18:30:11Z","timestamp":1582223411000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419571654"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,4]]},"references-count":12,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1999,4]]}},"alternative-id":["S0923753419571654"],"URL":"https:\/\/doi.org\/10.1023\/a:1008397424359","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[1999,4]]}}}